Nanovis’ technology portfolio, with supporting intellectual property may be used to differentiate implants in a wide range of implant markets. Nanovis is focused on the degenerative spine market with long term expansion plans for other orthopedic markets. Please contact Nanovis if you are interested in using Nanovis’ technology to create a competitive advantage for implants or biomaterials in bone or soft tissue markets.